Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

NobelReplace CC TiUltra RP 4.3x16mm: medical device reports filed with FDA

506 reports name it, 2021–2026. Manufacturer given most often on reports: Nobel Biocare. Product code DZE.

506
device reports naming the brand
0% of all MAUDE reports · about 92 a year
136
reports, 12 months to August 2026
96 in the 12 months before
1.8%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 506 reports that name the brand "NobelReplace CC TiUltra RP 4.3x16mm" (endosseous dental implant), received between January 2021 and August 2026; the manufacturer given most often on reports is Nobel Biocare. Spellings of one product vary from report to report.

136 reports arrived in the 12 months to August 2026, up 42% from 96 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (98.2%) and malfunction (1.8%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (70.8%), osseointegration problem (11.9%) and loss of osseointegration (7.9%). The patient problems coded most often are failure of implant, pain and abscess. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

01122Sep 2021: 3Oct 2021: 8Nov 2021: 2Dec 2021: 82022Jan 2022: 0Feb 2022: 8Mar 2022: 4Apr 2022: 4May 2022: 6Jun 2022: 6Jul 2022: 4Aug 2022: 20Sep 2022: 6Oct 2022: 8Nov 2022: 2Dec 2022: 02023Jan 2023: 2Feb 2023: 8Mar 2023: 18Apr 2023: 4May 2023: 4Jun 2023: 4Jul 2023: 10Aug 2023: 10Sep 2023: 12Oct 2023: 8Nov 2023: 10Dec 2023: 22024Jan 2024: 22Feb 2024: 6Mar 2024: 8Apr 2024: 4May 2024: 18Jun 2024: 2Jul 2024: 8Aug 2024: 8Sep 2024: 16Oct 2024: 4Nov 2024: 4Dec 2024: 22025Jan 2025: 4Feb 2025: 14Mar 2025: 12Apr 2025: 0May 2025: 0Jun 2025: 2Jul 2025: 20Aug 2025: 18Sep 2025: 8Oct 2025: 16Nov 2025: 14Dec 2025: 22026Jan 2026: 20Feb 2026: 16Mar 2026: 12Apr 2026: 22May 2026: 4Jun 2026: 8Jul 2026: 6Aug 2026: 8

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

0551102021: 3820212022: 6820222023: 9220232024: 10220242025: 11020252026: 962026

Event type and report source

Event type, as classified on the report

Death0%0
Injury98.2%497
Malfunction1.8%9
Other0%0
Not given0%0

Who filed the report

Manufacturer report50%253
Voluntary report0%0
User facility report0%0
Distributor report50%253
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate35870.8%62.8%
Osseointegration problem6011.9%7.7%
Loss of osseointegration407.9%22.4%
Insufficient device problem information122.4%0.2%
Difficult to insertthe device was hard to insert81.6%0.4%
Patient device interaction problem81.6%0.3%
Activation, positioning or separation problem61.2%0%
Device markings/labelling problema problem with the device markings or label20.4%0%
Fracturea broken bone20.4%1.6%
Material deformation20.4%0.1%
Migrationthe device moved from where it was placed20.4%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant30860.9%
Painpain, site not specified305.9%
Abscessa collection of pus81.6%
Numbnessnumbness81.6%
Appropriate clinical signs, symptoms and conditions term/code not available61.2%
Fistula40.8%
Implant pain40.8%
Inflammationinflammation40.8%
Osteomyelitis20.4%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureNobelReplace CC TiUltra RP 4.3x16mmProduct code DZEAll MAUDE reports
Reports5063,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury98.2%99.2%36.2%
Classified as malfunction1.8%0.8%62.3%
Filed by the manufacturer50%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about NobelReplace CC TiUltra RP 4.3x16mm reports

How many FDA reports name NobelReplace CC TiUltra RP 4.3x16mm?

506 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 136 in the latest 12 months.

What kinds of events are reported?

injury (98.2%) and malfunction (1.8%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (70.8%), osseointegration problem (11.9%), loss of osseointegration (7.9%), insufficient device problem information (2.4%) and difficult to insert (1.6%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (50%) and distributor reports (50%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that NobelReplace CC TiUltra RP 4.3x16mm was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.